U-Blot® Research Grade T10B9.1A-31Cat. No. WA3592Request quote
Size: 50ug/100ug
Overview
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade T10B9.1A-31Cat. No. WA3592U-Blot® Research Grade SYN-005-1B7Cat. No. WA3591Request quote
Size: 50ug/100ug
U-Blot® Research Grade SYN-005-11E6Cat. No. WA3590Request quote
Size: 50ug/100ug
U-Blot® Research Grade SuvratoxumabCat. No. WA3589Request quote
Size: 50ug/100ug
U-Blot® Research Grade suvonstobartCat. No. WA3588Request quote
Size: 50ug/100ug
U-Blot® Research Grade SuvizumabCat. No. WA3587Request quote
Size: 50ug/100ug
U-Blot® Research Grade SuvemcitugCat. No. WA3586Request quote
Size: 50ug/100ug
U-Blot® Research Grade SutimlimabCat. No. WA3585Request quote
Size: 50ug/100ug
U-Blot® Research Grade sutantatugCat. No. WA3584Request quote
Size: 50ug/100ug
U-Blot® Research Grade sutacimigCat. No. WA3583Request quote
Size: 50ug/100ug
U-Blot® Research Grade SurzebiclimabCat. No. WA3582Request quote
Size: 50ug/100ug
U-Blot® Research Grade surovatamigCat. No. WA3581Request quote
Size: 50ug/100ug
REQUEST A QUOTE
EMAILinfo@mail.ucallm.com
PHONE+(1)-866-986-9598
ONLINE FORMOnline Quote Submission
X+(1)-866-986-9598